Table 5.
L-Dex* Values by Group and Setting
| Healthy Volunteers (N=10) | Breast Cancer Survivors with Lymphedema (N=11) | P value | |
|---|---|---|---|
| Laboratory | |||
| L-Dex | |||
| Median | 1.96 | 14.96 | 0.029 |
| 25th–75th IQR | −0.34–2.89 | 2.05–39.84 | |
| Minimum | −8.08 | 0.02 | |
| Maximum | 4.66 | 106.78 | |
| L-Dex CV** | |||
| Median | 0.56 | 0.21 | 0.024 |
| 25th–75th IQR | 0.32–0.71 | 0.11–0.43 | |
| Minimum | 0.28 | 0.09 | |
| Maximum | 0.94 | 1.59 | |
| Home | |||
| L-Dex Mean | |||
| Median | 0.90 | 18.88 | 0.004 |
| 25th–75th IQR | −1.75–2.22 | 3.10–38.90 | |
| Minimum | −5.62 | −3.58 | |
| Maximum | 5.96 | 103.94 | |
| L-Dex CV | |||
| Median | 0.70 | 0.20 | 0.004 |
| 25th–75th IQR | 0.28–0.78 | 0.11–0.31 | |
| Minimum | 0.15 | 0.04 | |
| Maximum | 0.96 | 0.56 | |
Lymphedema index, based on impedance ratios of affected to nonaffected limbs; **Coefficient of variability.